期刊文献+

血清C超敏反应蛋白与2型糖尿病微量尿白蛋白的关系

下载PDF
导出
摘要 目的探讨血清超敏C反应蛋白(hsCRP)与新诊断2型糖尿病微量尿白蛋白的关系。方法选取112例新诊断2型糖尿病患者,根据24 h尿白蛋白(UAE)分为2组:正常白蛋白尿组(UAE<30 mg)(n=54)和微量白蛋白尿组(30<UAE<300 mg)(n=58)。采用免疫透射比子浊法测定血清hsCRP,采用放射免疫法检测尿白蛋白量。结果微量白蛋白尿组的SBP、PBG、hsCRP以及UAE水平明显高于正常白蛋白尿组,2组间的差异均具有统计学意义(P均<0.05);而2组间其他临床指标的差异均无统计学意义(P均>0.05)。Spearman相关性分析显示,hsCRP与UAE、SBP和BMI呈显著性相关(r=0.396,P=0.002;r=0.265,P=0.047;r=0.287,P=0.036),而且经过校正性别、年龄、SPB、FBG、PBG以及SCr后,hsCRP仍与UAE呈显著相关(r=0.271,P=0.039)。结论血清hsCRP水平与新诊断2型糖尿病UAE相关,从而支持CRP作为一种炎症介质,可能参与糖尿病血管病变的发生与发展。
出处 《实用临床医学(江西)》 CAS 2009年第2期8-10,共3页 Practical Clinical Medicine
  • 相关文献

参考文献10

  • 1Navarro J F, Mora C, Maca M, et al. Inflammatory Parameters are Independently Associated with Urinary Albumin in Type 2 Diabetes Mellitus[J]. Am J Kidney Dis, 2003,42 ( 1 ): 53-61.
  • 2Kang E S, Kim H J, Ahn C W, et al. Relationship of Serum High Sensitivity C-reactive Protein to Metabolic Syndrome and Microvascular Complications in Type 2 Diabetes[J]. Diabetes Res Clin Pract, 2005,69(2) : 151-159.
  • 3Kazemi Bajestani S M, Ghayour Mobarhan M, Ebrahimi M, et al. C-reactive Protein Associated with Coronary Artery Disease in Iranian Patients with Angiographically Defined Coronary Artery Disease[J]. Clin Lab, 2007,53 (1/2): 49-56.
  • 4王中心,黄一鑫.2型糖尿病大血管并发症与血清C-反应蛋白水平关系的研究[J].临床荟萃,2006,21(7):493-495. 被引量:11
  • 5Friedman A N, Hunsicker L G,Selhub J, et al. C-reactive Protein as a Predictor of Total Arteriosclerotic Outcomes in Type 2 Diabetic Nephropathy[J]. Kidney Int, 2005,68(2) : 773-778.
  • 6Rodriguez Moran M,Guerrero Romero F. Elevated Concentrations of C-reactive Protein in Subjects with Type 2 Diabetes Mellitus are Moderately Influenced by Glycemic Control[J]. J Endoerinol Invest, 2003,26 (3) : 216-221.
  • 7Akbar D H. Effect of Metformin and Sulfonylurea on C-reactive Protein Level in Well-controlled Type 2 Diabetics with Metabolic Syndrome[J]. Endocrine, 2003,20(3) :215-218.
  • 8Wang H R,Li J J,Huang C X,et al. Fluvastatin Inhibits the Expression of Tumor Necrosis Factor-alpha and Activation of Nuclear Faetor-kappaB in Human Endothelial Cells Stimulated by C-reactive Protein[J]. Clin Chim Acta, 2005,353 : 53-60.
  • 9Verma S, Li S H,Badiwala M V, et al. Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenie Effects of C-reactive Protein[J]. Circulation,2002,105 : 1890-1896.
  • 10Fujii H, Li S H, Szmitko P E, et al. C-reactive Protein Alters Antioxidant Defenses and Promotes Apoptosis in Endothelial Progenitor Cells[J]. Arterioscler Thrombosis Vasc Biol, 2006,26:2476-2482.

二级参考文献12

  • 1朱禧星.现代糖尿病学[M].上海:复旦大学出版社,2002.227.
  • 2陈灏珠 李宗明.内科学[M].北京:人民卫生出版社,2001..
  • 3Mojiminiyi OA,Abdella N,Moussa MA,et al.Association of C reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus[J].Diabetes Res Clin Pract,2002,58(1):37-44.
  • 4Volanakis JE.Human C reactive protein:expression,structure,and function[J].Mol Immunol,2001,38(23):189-197.
  • 5钱荣立.糖尿病临床指南[M].北京:北京医科大学出版社,2001.7-12.
  • 6Ross R.Atherosclerosis:an inflammatory disease[J].N Engl J Med,1999,340(2):115-126.
  • 7Ridker PM,Cushman M,Stampfer MJ,et al.Inflammation,aspirin and the risk of cardiovascular disease in apparently healthy men[J].N Engl J Med,1997,336(5):973-979.
  • 8Nader R,Russell P,Paul M,et al.Clinical efficacy of automated high-sensitivity C-reactive protein assay[J].Clin Chem,1999,12(12):2136-2141.
  • 9Taniguchi A,Nagasaka S,Fujushima M,et al.C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients[J].Metabolism,2002,51(12):1578-1581.
  • 10Abu-Lebdeh HS,Hodge DO,Nguyent TT.Predictors of macrovascular disease in patients with type 2 diabete mellitus[J].Mayo Clin Proc,2001,76(7):707-712.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部